AVITA MEDICAL INC's ticker is RCEL and the CUSIP is 05380C102. A total of 1 filers reported holding AVITA MEDICAL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,824 | -14.1% | 36,812 | 0.0% | 0.05% | -14.0% |
| Q2 2023 | $626,173 | +21.8% | 36,812 | 0.0% | 0.06% | +18.8% |
| Q1 2023 | $514,264 | +111.7% | 36,812 | 0.0% | 0.05% | +92.0% |
| Q4 2022 | $242,959 | +25.2% | 36,812 | 0.0% | 0.02% | +13.6% |
| Q3 2022 | $194,000 | +10.9% | 36,812 | 0.0% | 0.02% | +22.2% |
| Q2 2022 | $175,000 | -43.9% | 36,812 | 0.0% | 0.02% | -37.9% |
| Q1 2022 | $312,000 | -52.1% | 36,812 | 0.0% | 0.03% | -56.1% |
| Q3 2021 | $652,000 | -13.6% | 36,812 | 0.0% | 0.07% | -15.4% |
| Q2 2021 | $755,000 | +3.4% | 36,812 | 0.0% | 0.08% | -4.9% |
| Q1 2021 | $730,000 | +6.7% | 36,812 | 0.0% | 0.08% | 0.0% |
| Q4 2020 | $684,000 | -26.1% | 36,812 | 0.0% | 0.08% | -32.8% |
| Q3 2020 | $926,000 | +88.6% | 36,812 | +129.1% | 0.12% | +79.4% |
| Q2 2020 | $491,000 | – | 16,067 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 454,871 | $5,449,000 | 7.56% |
| Redmile Group, LLC | 672,411 | $8,055,000 | 0.18% |
| Capricorn Fund Managers Ltd | 22,287 | $267,000 | 0.08% |
| Clearline Capital LP | 50,343 | $603,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 800,000 | $9,584,000 | 0.05% |
| RTW INVESTMENTS, LP | 106,667 | $1,278,000 | 0.02% |
| PDT Partners, LLC | 18,135 | $217,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 34,477 | $405,000 | 0.01% |
| Artemis Investment Management LLP | 68,991 | $826,000 | 0.01% |
| Granahan Investment Management | 21,732 | $260,000 | 0.01% |